Takeda Pharmaceutical Ltd ADR (TAK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | TAK | ZTS | NBIX | ||
Company | Takeda Pharmaceutical Ltd ADR | Zoetis Inc Cl A | Neurocrine Bioscienc | ||
Price Information | |||||
Exchange | NYSE | NYSE | NASDAQ | ||
Open | 13.34 | 170.45 | 140.90 | ||
High | 13.41 | 171.69 | 141.88 | ||
Low | 13.30 | 166.95 | 139.23 | ||
Last | 13.37 | 167.07 | 140.71 | ||
Change | +0.10 | -0.16 | +0.88 | ||
% Change | +0.75% | -0.10% | +0.63% | ||
Volume | 1,333,900 | 3,007,100 | 616,500 | ||
20-Day Average Volume | 1,625,240 | 4,574,185 | 803,360 | ||
Previous Close | 13.27 | 167.23 | 139.83 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 13.30 | 156.63 | 136.80 | ||
20-Day Raw Stochastic | 47.40% | 82.82% | 70.11% | ||
20-Day Relative Strength | 44.05% | 52.97% | 54.80% | ||
Weighted Alpha | -20.15 | -11.45 | +45.16 | ||
Today's Opinion | 88% Sell | 56% Sell | 88% Buy | ||
Previous Opinion | 100% Sell | 64% Sell | 88% Buy | ||
Last Month's Opinion | 88% Sell | 56% Sell | 88% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +2.61% since 04/26/24 | +5.46% since 04/26/24 | +3.47% since 04/26/24 | ||
Low | 13.08 on 05/01/24 | 158.04 on 05/01/24 | 136.01 on 05/01/24 | ||
High | 13.41 on 05/03/24 | 171.69 on 05/03/24 | 145.22 on 05/01/24 | ||
1-Month | |||||
%Chg | -1.18% since 04/03/24 | +2.52% since 04/03/24 | +2.27% since 04/03/24 | ||
Low | 13.01 on 04/26/24 | 144.80 on 04/22/24 | 130.13 on 04/19/24 | ||
High | 13.77 on 04/08/24 | 171.69 on 05/03/24 | 145.22 on 05/01/24 | ||
3-Month | |||||
%Chg | -6.37% since 02/02/24 | -11.62% since 02/02/24 | -0.73% since 02/02/24 | ||
Low | 13.01 on 04/26/24 | 144.80 on 04/22/24 | 128.00 on 02/07/24 | ||
High | 14.88 on 02/27/24 | 200.53 on 02/29/24 | 148.37 on 03/21/24 | ||
6-Month | |||||
%Chg | -4.57% since 11/03/23 | +2.98% since 11/03/23 | +25.14% since 11/03/23 | ||
Low | 13.01 on 04/26/24 | 144.80 on 04/22/24 | 103.63 on 11/10/23 | ||
High | 15.07 on 01/12/24 | 201.92 on 12/14/23 | 148.37 on 03/21/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 42,313,872 | 76,410,976 | 14,160,632 | ||
Shares Outstanding, K | 3,164,837 | 457,359 | 100,637 | ||
Annual Sales | 29,803,340,000 | 8,544,000,000 | 1,887,100,000 | ||
Annual Net Income | 2,345,930,000 | 2,344,000,000 | 249,700,000 | ||
Last Quarter Sales | 7,556,070,000 | 2,213,000,000 | 515,200,000 | ||
Last Quarter Net Income | 718,900,000 | 525,000,000 | 147,700,000 | ||
60-Month Beta | 0.56 | 0.86 | 0.28 | ||
Per-Share Information | |||||
Most Recent Earnings | 0.51 on 02/01/24 | 1.38 on 05/02/24 | 0.42 on 05/01/24 | ||
Latest Earnings Date | 05/09/24 | 05/02/24 | 05/01/24 | ||
Most Recent Dividend | 0.261 on 09/28/23 | 0.432 on 04/18/24 | N/A | ||
Next Ex-Dividends Date | 09/28/23 | 04/18/24 | N/A | ||
Ratios | |||||
Price/Earnings ttm | 6.81 | 31.03 | 38.52 |